Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphate compound and uses thereof

Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphate compound and uses thereof

US Patent 11008361 · Granted May 18, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interactive user feedback system to enhance inspection accuracy of automated vis2025
FXR small molecule agonist and preparation method therefor and use thereof2025
Structures and mechanism for the design of highly potent glucocorticoids2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate co2021
Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate com2021
Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate com2021
Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate com2021
Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate com2021
Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific d2021